Yang investigated TP53 codon 72 polymorphisms in 435 patients with esophageal squamous cell carcinoma (ESCC) and 550 cancer-free subjects from the same geographical region (19). This evidence concerns the gene TP53 and esophageal squamous cell carcinoma.